RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
RELMADA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.16+0.06 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $355.11M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 13, 2019(first seen in filings) | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Sep 30, 2019 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Sep 11, 2015(first seen in filings) | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Aug 12, 2015 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |